Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA nudges BIO on marketing code

Executive Summary

Billy Tauzin, president of the Pharmaceutical Research and Manufacturers of America, is continuing to publicly pressure Jim Greenwood, president of Biotechnology Industry Organization, to adopt PhRMA's marketing code. BIO has been considering it, but says the code may be a difficult fit because few of its members market products and the products promoted are complex (1"The Pink Sheet" DAILY, Nov. 18, 2008). At a briefing for reporters Jan. 14, Tauzin said, "Jim tells me ... [that] sometime in February or March they are planning to make a decision, and hopefully they'll endorse the code." For its part, BIO said, "We have no specific timetable set for this discussion.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050568

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel